Literature DB >> 2848811

Nuclear factors interacting with the mitogen-responsive regulatory region of the interleukin-2 gene.

M W Brunvand1, A Schmidt, U Siebenlist.   

Abstract

We have investigated the interaction of nuclear factors with the regulatory region of the interleukin-2 (IL-2) growth factor gene, which is induced upon activation of T lymphocytes. The regulatory region of IL-2 has been defined previously on the basis of transient transfection experiments and DNase I hypersensitive site analyses. This region of about 275 base pairs contains both tissue-specific as well as activation-dependent elements. Here we demonstrate nuclear factors which bind in this region. Some of these interactions are cell type-specific and several depend on prior activation of cells. This suggests that multiple activation responsive elements reside in the IL-2 promoter region. The inducible DNA binding activity of one of the factors is dependent also on protein synthesis. We have established an in vitro transcription assay to assess functional requirements for these DNA binding proteins. The possible involvement of some of these factors in regulating other genes expressed in T cells is discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2848811

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1.

Authors:  C B Thompson; C Y Wang; I C Ho; P R Bohjanen; B Petryniak; C H June; S Miesfeldt; L Zhang; G J Nabel; B Karpinski
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

2.  Translocation of an erythroid-specific hypersensitive site in deletion-type hereditary persistence of fetal hemoglobin.

Authors:  J T Elder; W C Forrester; C Thompson; D Mager; P Henthorn; M Peretz; T Papayannopoulou; M Groudine
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

3.  Characterization of a protein that regulates the DNA-binding activity of NF-AT, the nuclear factor of activated T cells.

Authors:  A Granelli-Piperno; P McHugh
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

Review 4.  Calcium-NFAT transcriptional signalling in T cell activation and T cell exhaustion.

Authors:  Patrick G Hogan
Journal:  Cell Calcium       Date:  2017-01-28       Impact factor: 6.817

5.  Inducible nuclear factor binding to the kappa B elements of the human immunodeficiency virus enhancer in T cells can be blocked by cyclosporin A in a signal-dependent manner.

Authors:  A Schmidt; L Hennighausen; U Siebenlist
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

6.  In vivo footprinting of the human IL-2 gene reveals a nuclear factor bound to the transcription start site in T cells.

Authors:  M W Brunvand; A Krumm; M Groudine
Journal:  Nucleic Acids Res       Date:  1993-10-11       Impact factor: 16.971

7.  Regulatory anatomy of the murine interleukin-2 gene.

Authors:  T J Novak; P M White; E V Rothenberg
Journal:  Nucleic Acids Res       Date:  1990-08-11       Impact factor: 16.971

8.  Retinoic acid-induced down-regulation of the interleukin-2 promoter via cis-regulatory sequences containing an octamer motif.

Authors:  M P Felli; A Vacca; D Meco; I Screpanti; A R Farina; M Maroder; S Martinotti; E Petrangeli; L Frati; A Gulino
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

9.  Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT.

Authors:  F Paliogianni; A Raptis; S S Ahuja; S M Najjar; D T Boumpas
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

10.  BOB.1/OBF.1 controls the balance of TH1 and TH2 immune responses.

Authors:  Cornelia Brunner; Anca Sindrilaru; Irute Girkontaite; Klaus-Dieter Fischer; Cord Sunderkötter; Thomas Wirth
Journal:  EMBO J       Date:  2007-06-14       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.